Participant consumed grapefruit or grapefruit solutions within 3 days ahead of the primary dose of study drug. - Participant consumed grapefruit or grapefruit solutions within three days just before the main dose of study drug. In Segment C, participants will acquire ABBV-744 and oral navitoclax. In Section D, participants will https://abbv-744-brd4-inhibition78023.prublogger.com/31257887/5-easy-facts-about-abbv-744-brd4-inhibitor-mechanism-of-action-described